Research Papers

Click below links to view complete articles 

 

Year Articles
1966 A possible method for estimation of Bisphenol-A
1967 Epoxy-BPA
1967 Kinetics BPA Formation
1967 TLC BPA
1968 Estimation of Diglycidyl Ether in Epoxide Resins
1980 Penicillins
1980 Vitamin A
1981 Drugs and Pharma Industry Highlights
1981 Generics Policy And Drugs I-Approach to implementation
1981 Intermediates and bulk drugs production – Sixth Plan
1982 Helical Coil Heat Exgr
1982 Pharma Industry in India
1984 Guidelines for Entrepreneurs
1985 Rifampicin Global Status
1988 Local Anaesthetics
1988 Production of Therapeutic Polypeptides
1991 Microbial Gene Technology
1991 Recomb Ecoli
1992 Indian scenario on medical diagnostics business
1992 Biotechnology industries in India: Investment Opportunities
1992 Prospects of Biotech Industry India Human Animal
1992 Study of Diagnostics Market in India
1993 Endowment Lecture TNVAS
1994 Govt regulations licensing and approvals for the biotech industry
1995 Biotechnology and Development Review
1995 Indust Policy TRIPS Biotech
1996 Commercializing Indian Biotechnologies
1996 MIcrobial LIPASES
1997 GM Plants Ind Agri
1997 Transgenic plants and biosafety concerns in India
1998 Indian Penicillin Industry Turbulence Ahead Part I and II
1998 pH and Thermo sensitive nanoparticles
1999 Consultancy and its relevance to Biotechnology in India
1999 Strategies for manipulation of genes beta lactam antibiotics
1999 US PATENT Nano particles 5874111 Monodisperse Nanoparticles
1999 US5874111
2000 Indian Rules, Regulations and Procedures for handling Transgenic Plants
2000 GM Crops in India with special reference to Cotton
2000 A Journey from the Kingdom of Chemistry to the land of Biotechnology
2000 Biodistribution of Dextran
2000 GM Crops update Gen Art New India Digest NEW
2000 Hydrophillic-nanoparticles IJBB 37-5- 273-282
2000 Recent Advances in synthesis of modified oligonucleotides
2001 Prospects for Biotechnology in India
2001 Bt-Cotton Govt Procedures
2001 GM Crops Benefits Debate Economic Times
2001 IPR Issues in Biotechnology India
2001 PKG Article in The Hindu
2001 US PKG 6322817 Paclitaxel
2001 US6322817
2002 Commercialization and assessment of a rapid hiv antibody detection kit
2003 RFecent advances in ogilonucleotide synthesis Indain J Biochem And Biophy
2003 Rules GMOs India
2004 Comparative-evaluation of rapid and elisa kits for detection of hiv infection
2004 Role of allaince in modern biotech industries
2005 Comment on activity of commercial Strepto
2007 Accelerated composting of coir pith
2007 Advance in Biopharma INDIA REPRINT Chapter 1
2007 GM FOOD SAFETY VAK
2007 GM-CSF Review
2007 Human GM-CSF Review
2007 Sodium hyaluronate of defined osteoarthritis
2007 Induction of resistance in tea plants against root rot pathogens
2007 Bring rational regulatory regime for rDNA biotech products-The Economic Times
2008 Cadila Patent Mw 10 583 731 Vaccine Adjuvants p38 inhibitors
2008 Indian Efforts Biotech development
2008 Adv Biopharma Industry India Chap 1 Book
2010 Probiotic assisted colon specifc delivery
2011 Would healing potential of Apamarga leaves
2013 Phyto Extracts in Wound Healing
2014 Effects of probiotics addition and shellac coating from guar gum matrix tablets
2015 Predictive Perspectives of Disease—Transformed Protein Biomarkers
2016 Similar Biologics: Global Opportunities and Issues
2017 Identity Preservation System for LMOs in India-Feasibility Issues
2019 Policies and Growth of Pharmaceutical Industry in India-A Review
2019 Human Vaccines in India: Present and Future Perspectives
2020 Human vaccines industry in China, 2019: Part—I
2020 Human vaccines industry in China, 2019: Part II
2020 Human vaccines industry in China, 2019: Part III
2020 Tuberculosis-prone countries and resistance to COVID-19
2020 Effective SARS-CoV-2 Vaccines on the Horizon
2020 Utility of convalescent plasma for COVID-19 treatment
2021 Novel Active Pharmaceutical Ingredients from India: The Actors-Part-I
2021 Novel active pharmaceutical ingredients from India: The issues—Part-II
2021 Generation of efficacy data on 60 years and older population using SARS-CoV-2 vaccines
2021 Global efforts on vaccines development against SARS-CoV-2 and Indian endeavor
2022 Exploring clues for wide variations in COVID-19 fatality rates among countries
2022 Infectious human diseases: Regions, habitats, threats, and mitigation strategies: The actors—Part I
TOP